What is happening. Fatigue and low-energy symptoms attributed to declining NAD+ overlap substantially with symptoms of vitamin B12 deficiency, which is a far more common and directly treatable cause. Confirming and correcting B12 status addresses an established deficiency, whereas NR addresses a more speculative target.
Mechanism. Both are B-vitamin-related cofactors involved in energy metabolism, but through distinct pathways: B12 supports methionine synthase and methylmalonyl-CoA mutase, while NR feeds NAD+ redox metabolism. No competitive or pharmacokinetic interaction is established.
Recommendation. If energy or cognitive symptoms are the goal, evaluate and correct vitamin B12 (and folate, iron, thyroid) status first, since B12 deficiency is common and clearly treatable. NR can be added but should not displace that workup. No pharmacologic interaction between the two.